Improve your knowledge in Oncological Cardiology through this course, where you will find the best didactic material with real case studies"

Cardiac toxicity (CT) occurs in up to 30% of the millions of patients treated today for oncological processes. This is a "serious complication that usually debuts as heart failure and negatively affects the prognosis" of patients. The onset and severity of CT related to oncologic treatment are varied, depending mainly on each patient's individual susceptibility, the mechanism of action of the therapy, the capacity for early detection and the establishment of targeted treatment.

The objective of this course is to offer updated training in an area of current relevance from the clinical point of view, whose knowledge is advancing at a dizzying pace, focused on the training of professionals interested in the subject. 

Cardiologists, oncologists and hematologists with special interest in this field have with this course the opportunity to complete and update their knowledge in oncologic cardiology. The final objective of this training will be that students learn the pathophysiological basis of the genesis of CT, as well as the ways to detect and treat it. Students will get to know, understand and apply the latest diagnostic techniques, and preventive and therapeutic measures specific to CT in oncology patients.

Emphasis will be placed on "complex clinical problem solving" through case studies based on real-life situations. In addition, it offers a unique opportunity to learn about the latest research advances in this high-demand field. 

Learn about the latest advances in the specialty to be able to perform a quality medical practice".

This Postgraduate certificate in Introduction to Cardio-Oncology offers you the characteristics of a high level scientific, teaching and technological course.  These are some of its most notable features:

• Latest technology in online teaching software
• Highly visual teaching system, supported by graphic and schematic contents that are easy to assimilate and understand 
• Practical cases presented by practising experts
• State-of-the-art interactive video systems
• Teaching supported by telepractice
• Continuous updating and recycling systems
• Self-regulating learning: full compatibility with other occupations
• Practical exercises for self-evaluation and learning verification
• Support groups and educational synergies: questions to the expert, debate and knowledge forums
• Communication with the teacher and individual reflection work
• Content that is accessible from any fixed or portable device with an Internet connection
• Banks of complementary documentation permanently available, even after the course

This course may be the best investment you can make in the selection of a refresher program for two reasons: in addition to updating your knowledge in Introduction to Cardio-Oncology, you will obtain a course degree from TECH Global University - Technological University"

Our teaching staff is composed of professionals belonging to the field of Oncologic Cardiology. In this way, we ensure that we provide you with the training update we are aiming for. A multidisciplinary team of doctors trained and experienced in different environments, who will develop the theoretical knowledge in an efficient way, but, above all, will put at the service of the Course the practical knowledge derived from their own experience: one of the differential qualities of this Course.

This mastery of the subject is complemented by the effectiveness of the methodological design of this course. Developed by a multidisciplinary team of e-learning experts, it integrates the latest advances in educational technology. This way, you will be able to study with a range of comfortable and versatile multimedia tools that will give you the operability you need in your training. 

The design of this program is based on Problem-Based Learning: an approach that conceives learning as an eminently practical process. To achieve this remotely, we will use telepractice:  With the help of an innovative interactive video system, and learning from an expert, you will be able to acquire the knowledge as if you were actually dealing with the scenario you are learning about. A concept that will allow you to integrate and fix learning in a more realistic and permanent way.

It includes clinical cases that bring the development of the program as close as possible to the reality of medical care.

You will have professionals in the sector to guide you throughout the training process"

The structure of the contents has been designed by a team of professionals from the best hospitals and universities in the country, who are aware of the relevance of up-to-date training to be able to intervene in the diagnosis and treatment of heart problems in oncology patients through the use of Cardio-Oncology, and are committed to quality teaching through new educational technologies.

Train with renowned professionals, who will provide you with their knowledge and experience in Cardio-Oncology"

Module 1. Epidemiology of Cancer

1.1. Epidemiological Significance of Cancer
1.2. Epidemiological Significance of Cardiotoxicity in Oncology
1.3. Epidemiological Significance of Cardiotoxicity in Hematology

Module 2. Oncologic Treatments with Cardiotoxic Effect

2.1. Definition of Cardiotoxicity. Affected Cardiac Chambers. Pathophysiological Mechanisms of Cardiotoxicity
2.2. Radiotherapy as a Cause of Cardiotoxicity

2.2.1. Evolution of Radiotherapy Equipment and Methods
2.2.2. Factors that Influence Radiation-Induced Cardiotoxicity
2.2.3. Acute Toxicity
2.2.4. Chronic Toxicity

2.3. Chemotherapy as a Cause of Cardiotoxicity

2.3.1. Anthracyclines
2.3.2. Antitubulin Drugs
2.3.3. Antimetabolites
2.3.4. Alkylating Agents and Other Drugs that Interact with DNA

2.4. Biological Agents as a Cause of Cardiotoxicity: Monoclonal Antibodies

2.4.1. Trastuzumab
2.4.2. Other Monoclonal Antibodies

2.5. Other Potentially Cardiotoxic Biological Agents

2.5.1. Cytokines
2.5.2. Interferons

2.6. Therapies Aimed at New Molecular Targets and Cardiotoxicity: Inhibitors of Cellular Kinases
2.7. Immune Checkpoint Inhibitors and Cardiotoxicity
2.8. Other Potentially Cardiotoxic Oncologic Treatments

2.8.1. Histone Deacetylase Inhibitors
2.8.2. Oral Antiangiogenics
2.8.3. Differentiation and/or Apoptosis Inducers
2.8.4. Hormonal Agents

A unique, key, and decisive training experience to boost your professional development”